The pandemic is over, peaking in December with the arrival of the Omicron variant, and we were lucky it was a coronavirus and not another ’flu.
This pandemic has petered out relatively quickly because most of the developed world managed to quickly and effectively vaccinate the vulnerable.
With the rapid spread of the Omicron variant, many people who did not want to be vaccinated got vaccinated naturally, by exposure to the relatively harmless new variant.
Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost effectively than the traditional biotech model.
